Preliminary studies suggest that the compound – a dual activator of GLP-1 and a related hormone receptors – offers a significant advance in body management efforts . In contrast to existing medications , Retatrutide seems to affect appetite and energy burn through separate routes. While further investigation is required , the results spark hope